Clinical trials
Active, not recruiting Carcinoma, Hepatocellular trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
168 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2013 | 2 |
| 2014 | 3 |
| 2015 | 3 |
| 2016 | 3 |
| 2017 | 8 |
| 2018 | 11 |
| 2019 | 15 |
| 2020 | 13 |
| 2021 | 26 |
| 2022 | 21 |
| 2023 | 24 |
| 2024 | 19 |
| 2025 | 14 |
| 2026 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 168 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 9 |
| AstraZeneca | 8 |
| National Cancer Institute (NCI) | 6 |
| AbbVie | 4 |
| City of Hope Medical Center | 4 |
| Seoul National University Hospital | 4 |
| Sun Yat-sen University | 4 |
| Asan Medical Center | 3 |
| Assistance Publique - Hôpitaux de Paris | 3 |
| Eisai Inc. | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Hepatocellular | 168 |
| Liver Neoplasms | 27 |
| Carcinoma, Non-Small-Cell Lung | 13 |
| Carcinoma, Renal Cell | 12 |
| Melanoma | 12 |
| Neoplasms | 11 |
| Colorectal Neoplasms | 10 |
| Cholangiocarcinoma | 9 |
| Squamous Cell Carcinoma of Head and Neck | 9 |
| Triple Negative Breast Neoplasms | 9 |
Trials
Showing 26 to 50 of 168. Each trial links to its page on Pharma Observatory.
68 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.